The Conductor of the Autonomic Orchestra
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Bad bedfellows - autonomic dysfunction, inflammation, and diabetes! Are they related? How? Evidence suggests the activation of inflammatory cytokines like IL-6 and TNFα in newly diagnosed type 2 diabetes and that the inflammatory change correlates with abnormalities in sympathovagal balance. Dysfunction of the autonomic system predicts cardiovascular risk and sudden death in patients with type 2 diabetes. It occurs in prediabetes, providing opportunities for early intervention. The importance of recognizing autonomic dysfunction as a predictor of morbidity and mortality with intensification of treatment suggests that all patients with type 2 diabetes at onset, and those with type 1 diabetes after 5 years should be screened for autonomic imbalance. These tests can be performed at the bedside with real time output of information - within the scope of the practicing physician - facilitates diagnosis and allows the application of sound strategies for management. The window of opportunity for aggressive control of all the traditional risk factors for cardiovascular events or sudden death with intensification of therapy is with short duration diabetes, the absence of cardiovascular disease, and a history of severe hypoglycemic events. To this list we can now add autonomic dysfunction and neuropathy, which have become the most powerful predictors of risk for mortality. It seems prudent that practitioners should be encouraged to become familiar with this information and apply risk stratification in clinical practice. After all, how difficult is it to ask patients "do you have numb feet?" and to determine their heart rate variability - it could be lifesaving. Ultimately methods to reset the hypothalamus and the inflammatory cascade are needed if we are to impact the care of patients with this compendium of conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
Gæde, P., Vedel, P., Larsen, N., Jensen, G. V. H., Parving, H.-H., & Pedersen, O. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021778 · Cited by 4,378 · cited 1×
“Intervention studies have documented the protective effects of glycemic control in type 1 diabetes (DCCT) and of multifactorial strategy aimed at lifestyle change with pharmacological correction of hyperglycemia, hypertension, dyslipidemia, and microalbuminuria (Gaede et al., 2003).”
BackgroundVagus nerve stimulation attenuates the systemic inflammatory response to endotoxin
Borovikova, L. V., Ivanova, S., Zhang, M., Yang, H., Botchkina, G. I., Watkins, L. R., Wang, H., Abumrad, N., Eaton, J. W., & Tracey, K. J. (2000) · Nature · doi:10.1038/35013070 · Cited by 4,211
Effect of a multifactorial intervention on mortality in type 2 diabetes
Gæde, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706245 · Cited by 3,465
Tesfaye, S., Boulton, A. J. M., Dyck, P. J., Freeman, R., Horowitz, M., Kempler, P., Lauria, G., Malik, R. A., Spallone, V., Vinik, A., et al. (2010) · Diabetes Care · doi:10.2337/dc10-1303 · Cited by 2,690 · cited 3×
“In fact, it is one of the only drugs targeting the nervous system to be endorsed by the Toronto consensus (Tesfaye et al., 2010).”
BackgroundSelf-citationTracey, K. J. (2009) · Nature Reviews Immunology · doi:10.1038/nri2566 · Cited by 1,154 · cited 4×
“The afferent arc consists of nerves that sense the injury and infection and this in turn activates a cholinergic antiinflammatory pathway that modulates the response and is the potential target for future therapies of diabetes (Borovikova et al., 2000; Tracey, 2009).”
BackgroundInfluentialGæde, P., Vedel, P., Parving, H.-H., & Pedersen, O. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07368-1 · Cited by 981 · cited 1×
“…adjusted with agents that act on one or other arm of the autonomic nervous system (Vinik et al., 2011; Figure 7) Gaede in the Steno memorial study (Gaede et al., 1999, 2008) showed that a multifactorial intervention controlling BP, lipids, and hyperglycemia reduces abnormalities in autonomic…”
BackgroundSpallone, V., Ziegler, D., Freeman, R., Bernardi, L., Frontoni, S., Pop‐Busui, R., Stevens, M., Kempler, P., Hilsted, J., Tesfaye, S., et al. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1239 · Cited by 957 · cited 1×
“While a number of tests for autonomic dysfunction are in the research arena some have been shown to be sufficiently robust to be incorporated into routine clinical care (Tesfaye et al., 2010; Spallone et al., 2011) (Table 2).”
BackgroundLa Rovere, M. T., Pinna, G. D., Maestri, R., Mortara, A., Capomolla, S., Febo, O., Ferrari, R., Franchini, M., Gnemmi, M., Opasich, C., et al. (2003) · Circulation · doi:10.1161/01.cir.0000047275.25795.17 · Cited by 917
Huston, J. M., Ochani, M., Rosas-Ballina, M., Liao, H., Ochani, K., Pavlov, V. A., Gallowitsch-Puerta, M., Ashok, M., Czura, C. J., Foxwell, B., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052362 · Cited by 683 · cited 1×
“For example, electrical stimulation of the vagus nerve or administration of the a7nACHR agonists reduces the magnitude of the inflammatory response by 50–75% without compromising cytokine activity (Borovikova et al., 2000; Bernik et al., 2002; Saeed et al., 2005; Huston et al., 2006).”
BackgroundMuscarinic acetylcholine receptors: mutant mice provide new insights for drug development
Wess, J., Eglen, R. M., & Gautam, D. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2379 · Cited by 637
Pop-Busui, R., Evans, G. W., Gerstein, H. C., Fonseca, V., Fleg, J. L., Hoogwerf, B. J., Genuth, S., Grimm, R. H., Corson, M. A., Prineas, R., et al. (2010) · Diabetes Care · doi:10.2337/dc10-0125 · Cited by 540 · cited 3×
“…duration of diabetes >12–15 years, impaired renal function, coronary artery calcification, a previous cardiovascular event, being African American, being female, aging, a history of neuropathy or numb feet, and loss in HRV (Calles-Escandon et al., 2010; Pop-Busui et al., 2010; Vinik et al., 2011).”
BackgroundZiegler, D., Hanefeld, M., Ruhnau, K. J., Mei\ner, H. P., Lobisch, M., Sch�tte, K., Gries, F. A., & The ALADIN Study Group (1995) · Diabetologia · doi:10.1007/bf00400603 · Cited by 525
Watkins, L. R., Goehler, L. E., Relton, J. K., Tartaglia, N., Silbert, L., Martin, D., & Maier, S. F. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(94)11105-r · Cited by 516 · cited 1×
“Watkins et al. (1995) discovered that sensory neurons detect the presence of inflammation in tissues (Figure 2).”
BackgroundHandelsman, Y., Mechanick, J. I., Blonde, L., Grunberger, G., Bloomgarden, Z. T., Bray, G. A., Dagogo-Jack, S., Davidson, J. A., Einhorn, D., Ganda, O., et al. (2011) · Endocrine Practice · doi:10.4158/ep.17.s2.1 · Cited by 513
Self-citationSaeed, R. W., Varma, S., Peng-Nemeroff, T., Sherry, B., Balakhaneh, D., Huston, J., Tracey, K. J., Al-Abed, Y., & Metz, C. N. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20040463 · Cited by 489 · cited 1×
“For example, electrical stimulation of the vagus nerve or administration of the a7nACHR agonists reduces the magnitude of the inflammatory response by 50–75% without compromising cytokine activity (Borovikova et al., 2000; Bernik et al., 2002; Saeed et al., 2005; Huston et al., 2006).”
BackgroundNot Available, N. A. (1998) · Diabetologia · doi:10.1007/s001250050924 · Cited by 308
RAGE-mediated signaling contributes to intraneuronal transport of amyloid-β and neuronal dysfunction
Takuma, K., Fang, F., Zhang, W., Yan, S., Fukuzaki, E., Du, H., Sosunov, A., McKhann, G., Funatsu, Y., Nakamichi, N., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905686106 · Cited by 290 · cited 1×
“Of further interest, RAGE knockout mice have a reduced capacity to develop neuropathy (Toth et al., 2008; Takuma et al., 2009), and the soluble form of the AGE receptor sRAGE, can act as a decoy molecule, thereby reducing the binding of ligands to RAGE and inhibiting the inflammatory cascade…”
BackgroundBalance training reduces falls risk in older individuals with type 2 diabetes
Morrison, S., Colberg, S. R., Mariano, M., Parson, H. K., & Vinik, A. I. (2010) · Diabetes Care · doi:10.2337/dc09-1699 · Cited by 230
Self-citationHeart rate variability as early marker of multiple organ dysfunction syndrome in septic patients
Pontet, J., Contreras, P., Curbelo, A., Medina, J., Noveri, S., Bentancourt, S., & Migliaro, E. R. (2003) · Journal of Critical Care · doi:10.1016/j.jcrc.2003.08.005 · Cited by 195 · cited 3×
“In rheumatoid arthritis high-frequency oscillation which reflect vagal activity are depressed compared with healthy controls (Pontet et al., 2003).”
BackgroundInfluentialThe contribution of the vagus nerve in interleukin-1β-induced fever is dependent on dose
Hansen, M. K., O'Connor, K. A., Goehler, L. E., Watkins, L. R., & Maier, S. F. (2001) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2001.280.4.r929 · Cited by 169
Calles-Escandón, J., Lovato, L. C., Simons-Morton, D. G., Kendall, D. M., Pop-Busui, R., Cohen, R. M., Bonds, D. E., Fonseca, V. A., Ismail-Beigi, F., Banerji, M. A., et al. (2010) · Diabetes Care · doi:10.2337/dc09-1471 · Cited by 160
Wu, J.-S., Yang, Y.-C., Lin, T.-S., Huang, Y.-H., Chen, J.-J., Lu, F.-H., Wu, C.-H., & Chang, C.-J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2175 · Cited by 98
Cited by
Young, H. A., & Benton, D. (2018) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000383 · Cited by 249
“Vinik (2012) noted that activation of inflammatory cytokines in newly diagnosed type 2 diabetes correlated with changes in sympatho–vagal balance.”
BackgroundAutonomic Neuropathy in Diabetes Mellitus
Verrotti, A., Prezioso, G., Scattoni, R., & Chiarelli, F. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00205 · Cited by 187
Dick, T. E., Hsieh, Y.-H., Dhingra, R. R., Baekey, D. M., Galán, R. F., Wehrwein, E., & Morris, K. F. (2014) · Progress in Brain Research · doi:10.1016/b978-0-444-63274-6.00010-2 · Cited by 178
Metadata
- Authors
- Vinik, A. I.
- Venue
- Frontiers in Endocrinology
- Publisher
- Frontiers Media SA
- Published
- 2012
- Volume
- 3
- Pages
- 71-71
- ISSN
- 1664-2392 (ISSN-L)
- OpenAlex
- W2026565815
- Cited by
- 57
- References
- 22
- FWCI
- 3.64
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.